Article Text
PostScript
Featured correspondence
Statistics from Altmetric.com
The Authors' reply In his letter1 referring to our Viewpoint article2 Dr Cattaneo argues that aspirin is not superfluous as an antithrombotic in the presence of strong P2Y12 receptor blockers, and probably provides additional benefit. At the same time it would seem that there is some common ground between us, as he also agrees that the most …
Footnotes
Linked article 216812.
Competing interests TDW has received research grant support and consultancy fees from Astrazeneca.
Provenance and peer review Commissioned; not externally peer reviewed.